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Background:
Scaffolds are defined as three-dimension porous solid biomaterials designed to perform some or all of
the following functions:
 promote cell-biomaterial interactions, cell adhesion, and extracellular matrix (ECM)
deposition
 permit sufficient transport of gases, nutrients, and regulatory factors to allow cell survival,
proliferation, and differentiation
 biodegrade at a controllable rate that approximates the rate of tissue regeneration under the
culture conditions of interest, and
 provoke a minimal degree of inflammation or toxicity in vivo.
Scaffolds can be used as replacements for diseased or damaged tissues.
Their role is to provide support for delivering cells and/or growth factors to the proposed site of tissue
regeneration.
THE AIM of this review was to describe the current types of scaffolds and evaluate their use in 
combination with stem cells for tissue engineering applications.
Functions of extracellular matrix (ECM) in native tissues and of scaffolds in engineered 
tissues
Functions of ECM in native tissues Functions of scaffolds in engineered tissues
1) Provides structural support for cells to reside
1) Provides structural support for exogenously
applied cells to attach, grow, migrate and
differentiate in vitro and in vivo
2) Contributes to the mechanical properties of tissues
2) Provides the shape and mechanical stability to the
tissue defect and gives the rigidity and stiffness to
the engineered tissues
3) Provides bioactive cues for cells to respond to
their microenvironment
3) Interacts with cells actively to facilitate activities
such as proliferation and differentiation
4) Acts as the reservoirs of growth factors and
potentiates their actions
4) Serves as delivery vehicle and reservoir for
exogenously applied growth-stimulating factors
5) Provides a flexible physical environment to allow
remodeling in response to tissue dynamic
processes such as wound healing
5) Provides a void volume for vascularization and
new tissue formation during remodeling
Results:
Tissue engineering aims to restore, maintain, or improve tissue functions that are defective or have 
been lost by different pathological conditions, either by developing biological substitutes or by 
reconstructing tissues. The general strategies adopted by tissue engineering can be classified into 
three groups:
1. implantation of isolated cells or cell substitutes into the organism
2. delivering of tissue-inducing substances (such as growth factors), and
3. placing cells on or within different matrices
The best scaffold for an engineered tissue should be the ECM of the target tissue in its native state.
Currently proposed scaffolds include those made of inorganic materials, organic or synthetic polymers, or of 
mixed materials (composite scaffolds).
These materials include natural polymers (collagen, chitin, alginate), synthetic polymers (Polyglycolic acid 
(PGA), Poly (lactic-co-glycolic acid) (PLGA), Poly (lactic acid) (PLA)), metals (titanium, nitinol), and 
ceramics such as calcium phosphates (hydroxyapatite, tricalcium phosphate), calcium sulphates, and biological 
glass.
Cells can be seeded onto the scaffold and culture in vitro to generate tissue before transplantation, or can be 
transplated cell-free scaffolds with incorporated signaling molecules which induce the homing of stem cells 
residing in tissues and promote their differentiation.
Cells and tissue response to a scaffold depend upon the composition of the scaffold, its surface microstructure 
and three-dimensional architecture.
Scaffolds should have appropriate porosity and the mechanical properties that are appropriate for the cells and 
their macro- and microenvironments
The concept of tissue engineering is being applied for treatment of salivary gland disorders, regeneration of 
craniofacial tissues, oral mucose, periodontium, dentin and dental pulp.
Bio-oss ®, the most common natural biomaterial, is considered as the “gold standard” in bone tissue replacement 
in oral and maxillofacial surgery.
But, in recent years, there has been  an increasing use of composite scaffolds with ceramic and  polymer phases.
Porous hydroxyapatite (pHAP) is often used for the ceramic phase, because of its excellent osteoconductivity and 
even osteoinductivity. For polymer phase,  poly(lactic-co-glycolic) acid (PLGA) is approved as biodegradable,
biocompatible and noncytotoxic, and may improve chemical and functional properties of different ceramic scaffold 






The impact of tissue engineering and potential applications of stem cells to reconstruct different dental, oral, and 
craniofacial tissues and structures extend well beyond craniofacial and dental practices.
The use of scaffolds can overcome the drawbacks of traditional bone graft materials and offer a novel way for 
bone repair and regeneration.
Methods and  materials:
We searched for published studies, clinical trials and  review papers, reported from  2008. to 2014. in 
PubMed by using keywords: scaffold,  regenerative medicine, stem cells, tissue engineering, signaling 
molecules. 
Sanchez-Lara P.A et al. Impact of stem cells in craniofacial regenerative medicine Front. Physiol, 21 June 2012, doi: 10.3389/fphys.2012.00188
Currently, the association of  cells, scaffolds and signaling molecules, composing bioactive constructs, is 
proposed to be the best option for tissue engineering.
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